{"id":"https://openalex.org/W2097872088","doi":"https://doi.org/10.12968/hmed.2014.75.5.264","title":"Hyperprolactinaemia and psychotropics: endocrine effects and treatment","display_name":"Hyperprolactinaemia and psychotropics: endocrine effects and treatment","publication_year":2014,"publication_date":"2014-05-02","ids":{"openalex":"https://openalex.org/W2097872088","doi":"https://doi.org/10.12968/hmed.2014.75.5.264","mag":"2097872088","pmid":"https://pubmed.ncbi.nlm.nih.gov/25040270"},"language":"en","primary_location":{"id":"doi:10.12968/hmed.2014.75.5.264","doi":"https://doi.org/10.12968/hmed.2014.75.5.264","is_oa":false,"landing_page_url":"https://doi.org/10.12968/hmed.2014.75.5.264","pdf_url":null,"source":{"id":"https://openalex.org/S4210195120","display_name":"British Journal of Hospital Medicine","issn_l":"0007-1064","issn":["0007-1064","1750-8460","1759-7390"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321016","host_organization_name":"MA Healthcare","host_organization_lineage":["https://openalex.org/P4310321016"],"host_organization_lineage_names":["MA Healthcare"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Hospital Medicine","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5001782559","display_name":"Biju Jose","orcid":"https://orcid.org/0000-0001-9205-5161","observed_orcids":["https://orcid.org/0000-0001-9205-5161"]},"institutions":[{"id":"https://openalex.org/I2800115762","display_name":"University Hospitals of North Midlands NHS Trust","ror":"https://ror.org/03g47g866","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800115762"]},{"id":"https://openalex.org/I2800392559","display_name":"Royal Stoke University Hospital","ror":"https://ror.org/01dx1mr58","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800115762","https://openalex.org/I2800392559"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Biju Jose","raw_affiliation_strings":["Consultant in Endocrinology and Diabetes in the Department of Endocrinology and Diabetes University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant in Endocrinology and Diabetes in the Department of Endocrinology and Diabetes University Hospital of North Staffordshire, Stoke-on-Trent ST4 6QG","institution_ids":["https://openalex.org/I2800115762","https://openalex.org/I2800392559"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5071657984","display_name":"Sanju George","orcid":"https://orcid.org/0000-0003-4213-2258","observed_orcids":["https://orcid.org/0000-0003-4213-2258"]},"institutions":[{"id":"https://openalex.org/I2801901939","display_name":"Birmingham and Solihull Mental Health NHS Foundation Trust","ror":"https://ror.org/00cjeg736","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2801901939"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Sanju George","raw_affiliation_strings":["Consultant and Honorary Senior Lecturer in Addiction Psychiatry, Solihull Integrated Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Consultant and Honorary Senior Lecturer in Addiction Psychiatry, Solihull Integrated Addiction Services, Birmingham and Solihull Mental Health NHS Foundation Trust, Birmingham","institution_ids":["https://openalex.org/I2801901939"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.4358,"has_fulltext":false,"cited_by_count":2,"citation_normalized_percentile":{"value":0.64008528,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"75","issue":"5","first_page":"264","last_page":"267"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10832","display_name":"Pituitary Gland Disorders and Treatments","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10748","display_name":"Growth Hormone and Insulin-like Growth Factors","score":0.005499999970197678,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.0020000000949949026,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hyperprolactinemia","display_name":"hyperprolactinemia","score":0.9959999918937683},{"id":"https://openalex.org/keywords/psychotropic-drugs","display_name":"psychotropic drugs","score":0.968999981880188},{"id":"https://openalex.org/keywords/hypothalamic-pituitary-dysfunction","display_name":"hypothalamic-pituitary dysfunction","score":0.8320000171661377},{"id":"https://openalex.org/keywords/prolactin","display_name":"prolactin","score":0.7139999866485596}],"concepts":[{"id":"https://openalex.org/C2781401123","wikidata":"https://www.wikidata.org/wiki/Q1433936","display_name":"Hyperprolactinaemia","level":4,"score":0.9894553422927856},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9399089813232422},{"id":"https://openalex.org/C46699223","wikidata":"https://www.wikidata.org/wiki/Q11078","display_name":"Endocrine system","level":3,"score":0.6955581903457642},{"id":"https://openalex.org/C50965678","wikidata":"https://www.wikidata.org/wiki/Q2724302","display_name":"Abnormality","level":2,"score":0.5818583965301514},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3323303163051605},{"id":"https://openalex.org/C2779064019","wikidata":"https://www.wikidata.org/wiki/Q66590068","display_name":"Prolactin","level":3,"score":0.32470637559890747},{"id":"https://openalex.org/C71315377","wikidata":"https://www.wikidata.org/wiki/Q11364","display_name":"Hormone","level":2,"score":0.29770079255104065},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.2935996651649475}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":true},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":false},{"descriptor_ui":"D006966","descriptor_name":"Hyperprolactinemia","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D011619","descriptor_name":"Psychotropic Drugs","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.12968/hmed.2014.75.5.264","doi":"https://doi.org/10.12968/hmed.2014.75.5.264","is_oa":false,"landing_page_url":"https://doi.org/10.12968/hmed.2014.75.5.264","pdf_url":null,"source":{"id":"https://openalex.org/S4210195120","display_name":"British Journal of Hospital Medicine","issn_l":"0007-1064","issn":["0007-1064","1750-8460","1759-7390"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-20","russia-white-list-2"],"host_organization":"https://openalex.org/P4310321016","host_organization_name":"MA Healthcare","host_organization_lineage":["https://openalex.org/P4310321016"],"host_organization_lineage_names":["MA Healthcare"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Hospital Medicine","raw_type":"journal-article"},{"id":"pmid:25040270","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25040270","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of hospital medicine (London, England : 2005)","raw_type":"Journal Article"},{"id":"mag:2336017108","doi":null,"is_oa":false,"landing_page_url":"http://www.magonlinelibrary.com/doi/pdf/10.12968/hmed.2014.75.5.264","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W136070638","https://openalex.org/W154234585","https://openalex.org/W1230491582","https://openalex.org/W1483254641","https://openalex.org/W1916036599","https://openalex.org/W1973003196","https://openalex.org/W2013356327","https://openalex.org/W2019055295","https://openalex.org/W2022320465","https://openalex.org/W2032902988","https://openalex.org/W2042267709","https://openalex.org/W2076424478","https://openalex.org/W2077431656","https://openalex.org/W2080302100","https://openalex.org/W2166620991","https://openalex.org/W2607257274"],"related_works":["https://openalex.org/W2336017108","https://openalex.org/W3106923227","https://openalex.org/W2610975292","https://openalex.org/W2093106789","https://openalex.org/W2035868743","https://openalex.org/W2364288379","https://openalex.org/W2460224051","https://openalex.org/W3034381419","https://openalex.org/W2944627125","https://openalex.org/W4407889508"],"abstract_inverted_index":{"Hyperprolactinaemia":[0],"is":[1],"a":[2,12],"common":[3],"endocrine":[4],"abnormality.":[5],"Causes":[6],"are":[7],"multifactorial.":[8],"Medication":[9],"use":[10],"contributes":[11],"considerable":[13],"amount,":[14],"with":[15],"psychotropics":[16],"often":[17],"implicated,":[18],"although":[19],"underlying":[20],"hypothalamic\u2013pituitary":[21],"pathology":[22],"can":[23],"co-exist.":[24],"This":[25],"article":[26],"discusses":[27],"the":[28],"management":[29],"of":[30],"hyperprolactinaemia":[31],"during":[32],"psychotropic":[33],"use.":[34]},"counts_by_year":[{"year":2016,"cited_by_count":1},{"year":2014,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}